COMMUNIQUÉS West-GlobeNewswire

Onconova Therapeutics, Inc. Reports Business Highlights and First Quarter 2019 Financial Results
14/05/2019
NEWTOWN, Pa., May 14, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) , a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat [...]
Myriad Genetics to Present Multiple Studies at the 2019 American Society of Clinical Oncology Annual Meeting
14/05/2019
SALT LAKE CITY, May 14, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in personalized medicine, today announced that it will present results from multiple studies at the 2019 American Society [...]
Cronos Group and MediPharm Labs Enter $30 Million Multi-Year Private Label Cannabis Concentrate Supply Agreement with Potential to Increase to $60 Million
14/05/2019
Cronos Group and MediPharm Labs Enter Additional Multi-Year Tolling Arrangement TORONTO, May 14, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (“MediPharm Labs”) a leader in specialized, [...]
InspireMD Announces First Quarter 2019 Financial Results
14/05/2019
On-Track to Submit U.S. IDE expected in Mid-2019 Company to Host Investor Conference Call at 8:00am ET TEL AVIV, Israel, May 14, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ [...]
Cronos Group and MediPharm Labs Enter Cannabis Concentrate Supply Agreement
14/05/2019
Cronos Group and MediPharm Labs Enter Additional Multi-Year Tolling Arrangement TORONTO, May 14, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”), is pleased to [...]
Emerald Health Therapeutics étend la distribution de cannabis pour adultes à d'autres provinces
14/05/2019
VANCOUVER, Colombie-Britannique, 14 mai 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Emerald ») (TSXV: EMH; OTCQX: EMHTF) a été autorisée par PEI Cannabis et Manitoba Liquor & Lotteries Corporation [...]
OraSure Technologies to Hold Virtual Annual Meeting of Stockholders on May 21, 2019
14/05/2019
BETHLEHEM, Pa., May 14, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), announced that its 2019 Annual Meeting of Stockholders will be a completely virtual meeting, conducted as a live webcast [...]
Merus annonce le traitement d'un premier patient en phase 1 de l'essai clinique de MCLA‑145 pour des tumeurs solides avancées
14/05/2019
UTRECHT, Pays‑Bas, 14 mai 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), une entreprise d'immuno‑oncologie de stade clinique élaborant actuellement Biclonics®, des traitements innovants à base d'anticorps [...]
Zealand Pharma achieves primary and all key secondary endpoints in confirmatory Phase 3 trial with dasiglucagon for severe hypoglycemia
14/05/2019
Company announcement – No. 15 / 2019 Zealand Pharma achieves primary and all key secondary endpoints in confirmatory Phase 3 trial with dasiglucagon for severe hypoglycemia Primary and all key secondary endpoints [...]
Rutherford Diagnostics and Philips agree 10 year partnership to improve diagnostic services and patient outcomes across England
14/05/2019
May 14, 2019 Partnership to utilize innovative technology to increase access to diagnostic services with five new community sites across England Agreement aims to deliver first class, patient-centered diagnostic [...]
GN Store Nord A/S utilises attractive market conditions and launches refinancing of convertible bond, consisting of Bond with Warrant Units
14/05/2019
NOT FOR DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ITALY, OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW. [...]
Aino Health AB (publ): Aino Health interim report January-March 2019
14/05/2019
14 May 2019 Aino Health interim report January-March 2019 - Large deal with client in Finland, improved profit, net sales, and cash flow, the business model is showing results. January-March 2019 · Net sales increased [...]
GENFIT: Positive 36-month DSMB Recommendation for Continuation of Phase 3 RESOLVE-IT Study of Elafibranor in NASH
14/05/2019
GENFIT: Positive 36-month DSMB Recommendation for Continuation of Phase 3 RESOLVE-IT Study of Elafibranor in NASH Data Safety Monitoring Board (DSMB) recommends the continuation of the RESOLVE-IT clinical trial without [...]
GENFIT : Issue positive du DSMB à 36 mois, recommandant la poursuite de l’étude clinique de Phase 3 RESOLVE-IT évaluant elafibranor dans la NASH
14/05/2019
GENFIT : Issue positive du DSMB à 36 mois, recommandant la poursuite de l’étude clinique de Phase 3 RESOLVE-IT évaluant elafibranor dans la NASH Le Data Safety Monitoring Board (DSMB) a recommandé la poursuite de l’ [...]
DBV Technologies Announces Departure of Deputy CEO David Schilansky
14/05/2019
Montrouge, France, May 14, 2019 DBV Technologies Announces Departure of Deputy CEO David Schilansky DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical [...]
DBV Technologies Annonce le Départ de son Directeur Général Délégué, David Schilansky
14/05/2019
Montrouge, France, le 14 Mai (07h30 CET), 2019 DBV Technologies Annonce le Départ de son Directeur Général Délégué, David Schilansky DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Bourse Nasdaq : DBVT), [...]
Fagron NV: Fagron shareholders approve all proposed resolutions
14/05/2019
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), May 14 th , 2019 - 7:00am CET Fagron shareholders approve all proposed resolutions Fagron announces today that the annual general meeting of [...]
TOMI Environmental Solutions, Inc. to Hold First Quarter 2019 Financial Results Conference Call on Monday, May 20, 2019
14/05/2019
BEVERLY HILLS, Calif., May 13, 2019 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (OTCQX:TOMZ), a global company specializing in disinfection and decontamination essentials announced it will hold its [...]
Applied Therapeutics Announces Pricing of Initial Public Offering
14/05/2019
NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates against validated molecular targets in indications of [...]

Pages